Global Large Volume Parenterals (LVP) Market Research Report 2020

Publisher Name :
Date: 13-Feb-2020
No. of pages: 91
Inquire Before Buying

This report focuses on Large Volume Parenterals (LVP) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Large Volume Parenterals (LVP) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

- Ostuka Pharmaceutical (Japan)

- Teva Pharmaceutical Industries Limited (Israel)

- Kelun Pharma (China)

- Cook Pharmica LLC (Catalent) (US)

- Patheon Inc. (Netherlands)

- BAG Healthcare (Germany)

- Southwest Pharmaceutical Co. Ltd. (China)

- Beximco Pharma (Bangladesh)

- Baxter Healthcare Corporation (US)

Segment by Regions

- North America

- Europe

- China

- Japan

Segment by Type

- Fluid Balance Injections

- Therapeutic Injections

- Nutritious Injections

Segment by Application

- Intravenous

- Intramuscular

- Subcutaneous

- Others

Global Large Volume Parenterals (LVP) Market Research Report 2020

Table of Contents
1 Large Volume Parenterals (LVP) Market Overview
1.1 Product Overview and Scope of Large Volume Parenterals (LVP)
1.2 Large Volume Parenterals (LVP) Segment by Type
1.2.1 Global Large Volume Parenterals (LVP) Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Fluid Balance Injections
1.2.3 Therapeutic Injections
1.2.4 Nutritious Injections
1.3 Large Volume Parenterals (LVP) Segment by Application
1.3.1 Large Volume Parenterals (LVP) Sales Comparison by Application: 2020 VS 2026
1.3.2 Intravenous
1.3.3 Intramuscular
1.3.4 Subcutaneous
1.3.5 Others
1.4 Global Large Volume Parenterals (LVP) Market Size Estimates and Forecasts
1.4.1 Global Large Volume Parenterals (LVP) Revenue 2015-2026
1.4.2 Global Large Volume Parenterals (LVP) Sales 2015-2026
1.4.3 Large Volume Parenterals (LVP) Market Size by Region: 2020 Versus 2026
2 Global Large Volume Parenterals (LVP) Market Competition by Manufacturers
2.1 Global Large Volume Parenterals (LVP) Sales Market Share by Manufacturers (2015-2020)
2.2 Global Large Volume Parenterals (LVP) Revenue Share by Manufacturers (2015-2020)
2.3 Global Large Volume Parenterals (LVP) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Large Volume Parenterals (LVP) Manufacturing Sites, Area Served, Product Type
2.5 Large Volume Parenterals (LVP) Market Competitive Situation and Trends
2.5.1 Large Volume Parenterals (LVP) Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Large Volume Parenterals (LVP) Players (Opinion Leaders)
3 Large Volume Parenterals (LVP) Retrospective Market Scenario by Region
3.1 Global Large Volume Parenterals (LVP) Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Large Volume Parenterals (LVP) Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Large Volume Parenterals (LVP) Market Facts & Figures by Country
3.3.1 North America Large Volume Parenterals (LVP) Sales by Country
3.3.2 North America Large Volume Parenterals (LVP) Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Large Volume Parenterals (LVP) Market Facts & Figures by Country
3.4.1 Europe Large Volume Parenterals (LVP) Sales by Country
3.4.2 Europe Large Volume Parenterals (LVP) Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Large Volume Parenterals (LVP) Market Facts & Figures by Region
3.5.1 Asia Pacific Large Volume Parenterals (LVP) Sales by Region
3.5.2 Asia Pacific Large Volume Parenterals (LVP) Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Large Volume Parenterals (LVP) Market Facts & Figures by Country
3.6.1 Latin America Large Volume Parenterals (LVP) Sales by Country
3.6.2 Latin America Large Volume Parenterals (LVP) Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Large Volume Parenterals (LVP) Market Facts & Figures by Country
3.7.1 Middle East and Africa Large Volume Parenterals (LVP) Sales by Country
3.7.2 Middle East and Africa Large Volume Parenterals (LVP) Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Large Volume Parenterals (LVP) Historic Market Analysis by Type
4.1 Global Large Volume Parenterals (LVP) Sales Market Share by Type (2015-2020)
4.2 Global Large Volume Parenterals (LVP) Revenue Market Share by Type (2015-2020)
4.3 Global Large Volume Parenterals (LVP) Price Market Share by Type (2015-2020)
4.4 Global Large Volume Parenterals (LVP) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Large Volume Parenterals (LVP) Historic Market Analysis by Application
5.1 Global Large Volume Parenterals (LVP) Sales Market Share by Application (2015-2020)
5.2 Global Large Volume Parenterals (LVP) Revenue Market Share by Application (2015-2020)
5.3 Global Large Volume Parenterals (LVP) Price by Application (2015-2020)
6 Company Profiles and Key Figures in Large Volume Parenterals (LVP) Business
6.1 Ostuka Pharmaceutical (Japan)
6.1.1 Corporation Information
6.1.2 Ostuka Pharmaceutical (Japan) Description, Business Overview and Total Revenue
6.1.3 Ostuka Pharmaceutical (Japan) Large Volume Parenterals (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Ostuka Pharmaceutical (Japan) Products Offered
6.1.5 Ostuka Pharmaceutical (Japan) Recent Development
6.2 Teva Pharmaceutical Industries Limited (Israel)
6.2.1 Teva Pharmaceutical Industries Limited (Israel) Large Volume Parenterals (LVP) Production Sites and Area Served
6.2.2 Teva Pharmaceutical Industries Limited (Israel) Description, Business Overview and Total Revenue
6.2.3 Teva Pharmaceutical Industries Limited (Israel) Large Volume Parenterals (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Teva Pharmaceutical Industries Limited (Israel) Products Offered
6.2.5 Teva Pharmaceutical Industries Limited (Israel) Recent Development
6.3 Kelun Pharma (China)
6.3.1 Kelun Pharma (China) Large Volume Parenterals (LVP) Production Sites and Area Served
6.3.2 Kelun Pharma (China) Description, Business Overview and Total Revenue
6.3.3 Kelun Pharma (China) Large Volume Parenterals (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Kelun Pharma (China) Products Offered
6.3.5 Kelun Pharma (China) Recent Development
6.4 Cook Pharmica LLC (Catalent) (US)
6.4.1 Cook Pharmica LLC (Catalent) (US) Large Volume Parenterals (LVP) Production Sites and Area Served
6.4.2 Cook Pharmica LLC (Catalent) (US) Description, Business Overview and Total Revenue
6.4.3 Cook Pharmica LLC (Catalent) (US) Large Volume Parenterals (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Cook Pharmica LLC (Catalent) (US) Products Offered
6.4.5 Cook Pharmica LLC (Catalent) (US) Recent Development
6.5 Patheon Inc. (Netherlands)
6.5.1 Patheon Inc. (Netherlands) Large Volume Parenterals (LVP) Production Sites and Area Served
6.5.2 Patheon Inc. (Netherlands) Description, Business Overview and Total Revenue
6.5.3 Patheon Inc. (Netherlands) Large Volume Parenterals (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Patheon Inc. (Netherlands) Products Offered
6.5.5 Patheon Inc. (Netherlands) Recent Development
6.6 BAG Healthcare (Germany)
6.6.1 BAG Healthcare (Germany) Large Volume Parenterals (LVP) Production Sites and Area Served
6.6.2 BAG Healthcare (Germany) Description, Business Overview and Total Revenue
6.6.3 BAG Healthcare (Germany) Large Volume Parenterals (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.6.4 BAG Healthcare (Germany) Products Offered
6.6.5 BAG Healthcare (Germany) Recent Development
6.7 Southwest Pharmaceutical Co. Ltd. (China)
6.6.1 Southwest Pharmaceutical Co. Ltd. (China) Large Volume Parenterals (LVP) Production Sites and Area Served
6.6.2 Southwest Pharmaceutical Co. Ltd. (China) Description, Business Overview and Total Revenue
6.6.3 Southwest Pharmaceutical Co. Ltd. (China) Large Volume Parenterals (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Southwest Pharmaceutical Co. Ltd. (China) Products Offered
6.7.5 Southwest Pharmaceutical Co. Ltd. (China) Recent Development
6.8 Beximco Pharma (Bangladesh)
6.8.1 Beximco Pharma (Bangladesh) Large Volume Parenterals (LVP) Production Sites and Area Served
6.8.2 Beximco Pharma (Bangladesh) Description, Business Overview and Total Revenue
6.8.3 Beximco Pharma (Bangladesh) Large Volume Parenterals (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Beximco Pharma (Bangladesh) Products Offered
6.8.5 Beximco Pharma (Bangladesh) Recent Development
6.9 Baxter Healthcare Corporation (US)
6.9.1 Baxter Healthcare Corporation (US) Large Volume Parenterals (LVP) Production Sites and Area Served
6.9.2 Baxter Healthcare Corporation (US) Description, Business Overview and Total Revenue
6.9.3 Baxter Healthcare Corporation (US) Large Volume Parenterals (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Baxter Healthcare Corporation (US) Products Offered
6.9.5 Baxter Healthcare Corporation (US) Recent Development
7 Large Volume Parenterals (LVP) Manufacturing Cost Analysis
7.1 Large Volume Parenterals (LVP) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Large Volume Parenterals (LVP)
7.4 Large Volume Parenterals (LVP) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Large Volume Parenterals (LVP) Distributors List
8.3 Large Volume Parenterals (LVP) Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Large Volume Parenterals (LVP) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Large Volume Parenterals (LVP) by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Large Volume Parenterals (LVP) by Type (2021-2026)
10.2 Large Volume Parenterals (LVP) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Large Volume Parenterals (LVP) by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Large Volume Parenterals (LVP) by Application (2021-2026)
10.3 Large Volume Parenterals (LVP) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Large Volume Parenterals (LVP) by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Large Volume Parenterals (LVP) by Region (2021-2026)
10.4 North America Large Volume Parenterals (LVP) Estimates and Projections (2021-2026)
10.5 Europe Large Volume Parenterals (LVP) Estimates and Projections (2021-2026)
10.6 Asia Pacific Large Volume Parenterals (LVP) Estimates and Projections (2021-2026)
10.7 Latin America Large Volume Parenterals (LVP) Estimates and Projections (2021-2026)
10.8 Middle East and Africa Large Volume Parenterals (LVP) Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Large Volume Parenterals (LVP) Sales (K L) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Large Volume Parenterals (LVP) Sales (K L) Comparison by Application: 2020 VS 2026
Table 3. Global Large Volume Parenterals (LVP) Market Size by Type (K L) (US$ Million) (2020 VS 2026)
Table 4. Global Key Large Volume Parenterals (LVP) Manufacturers Covered in This Study
Table 5. Global Large Volume Parenterals (LVP) Sales (K L) by Manufacturers (2015-2020)
Table 6. Global Large Volume Parenterals (LVP) Sales Share by Manufacturers (2015-2020)
Table 7. Global Large Volume Parenterals (LVP) Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Large Volume Parenterals (LVP) Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Large Volume Parenterals (LVP) Average Price (USD/L) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Large Volume Parenterals (LVP) Sales Sites and Area Served
Table 11. Manufacturers Large Volume Parenterals (LVP) Product Types
Table 12. Global Large Volume Parenterals (LVP) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Large Volume Parenterals (LVP) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Large Volume Parenterals (LVP) as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Large Volume Parenterals (LVP) Players
Table 16. Global Large Volume Parenterals (LVP) Sales (K L) by Region (2015-2020)
Table 17. Global Large Volume Parenterals (LVP) Sales Market Share by Region (2015-2020)
Table 18. Global Large Volume Parenterals (LVP) Revenue (Million US$) by Region (2015-2020)
Table 19. Global Large Volume Parenterals (LVP) Revenue Market Share by Region (2015-2020)
Table 20. North America Large Volume Parenterals (LVP) Sales by Country (2015-2020) (K L)
Table 21. North America Large Volume Parenterals (LVP) Sales Market Share by Country (2015-2020)
Table 22. North America Large Volume Parenterals (LVP) Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Large Volume Parenterals (LVP) Revenue Market Share by Country (2015-2020)
Table 24. Europe Large Volume Parenterals (LVP) Sales by Country (2015-2020) (K L)
Table 25. Europe Large Volume Parenterals (LVP) Sales Market Share by Country (2015-2020)
Table 26. Europe Large Volume Parenterals (LVP) Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Large Volume Parenterals (LVP) Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Large Volume Parenterals (LVP) Sales by Region (2015-2020) (K L)
Table 29. Asia Pacific Large Volume Parenterals (LVP) Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Large Volume Parenterals (LVP) Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Large Volume Parenterals (LVP) Revenue Market Share by Region (2015-2020)
Table 32. Latin America Large Volume Parenterals (LVP) Sales by Country (2015-2020) (K L)
Table 33. Latin America Large Volume Parenterals (LVP) Sales Market Share by Country (2015-2020)
Table 34. Latin America Large Volume Parenterals (LVP) Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Large Volume Parenterals (LVP) Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Large Volume Parenterals (LVP) Sales by Country (2015-2020) (K L)
Table 37. Middle East and Africa Large Volume Parenterals (LVP) Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Large Volume Parenterals (LVP) Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Large Volume Parenterals (LVP) Revenue Market Share by Country (2015-2020)
Table 40. Global Large Volume Parenterals (LVP) Sales (K L) by Type (2015-2020)
Table 41. Global Large Volume Parenterals (LVP) Sales Share by Type (2015-2020)
Table 42. Global Large Volume Parenterals (LVP) Revenue (Million US$) by Type (2015-2020)
Table 43. Global Large Volume Parenterals (LVP) Revenue Share by Type (2015-2020)
Table 44. Global Large Volume Parenterals (LVP) Price (USD/L) by Type (2015-2020)
Table 45. Global Large Volume Parenterals (LVP) Sales (K L) by Application (2015-2020)
Table 46. Global Large Volume Parenterals (LVP) Sales Market Share by Application (2015-2020)
Table 47. Global Large Volume Parenterals (LVP) Sales Growth Rate by Application (2015-2020)
Table 48. Ostuka Pharmaceutical (Japan) Large Volume Parenterals (LVP) Corporation Information
Table 49. Ostuka Pharmaceutical (Japan) Description and Business Overview
Table 50. Ostuka Pharmaceutical (Japan) Large Volume Parenterals (LVP) Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2015-2020)
Table 51. Ostuka Pharmaceutical (Japan) Main Product
Table 52. Ostuka Pharmaceutical (Japan) Recent Development
Table 53. Teva Pharmaceutical Industries Limited (Israel) Large Volume Parenterals (LVP) Corporation Information
Table 54. Teva Pharmaceutical Industries Limited (Israel) Corporation Information
Table 55. Teva Pharmaceutical Industries Limited (Israel) Large Volume Parenterals (LVP) Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2015-2020)
Table 56. Teva Pharmaceutical Industries Limited (Israel) Main Product
Table 57. Teva Pharmaceutical Industries Limited (Israel) Recent Development
Table 58. Kelun Pharma (China) Large Volume Parenterals (LVP) Corporation Information
Table 59. Kelun Pharma (China) Corporation Information
Table 60. Kelun Pharma (China) Large Volume Parenterals (LVP) Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2015-2020)
Table 61. Kelun Pharma (China) Main Product
Table 62. Kelun Pharma (China) Recent Development
Table 63. Cook Pharmica LLC (Catalent) (US) Large Volume Parenterals (LVP) Corporation Information
Table 64. Cook Pharmica LLC (Catalent) (US) Corporation Information
Table 65. Cook Pharmica LLC (Catalent) (US) Large Volume Parenterals (LVP) Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2015-2020)
Table 66. Cook Pharmica LLC (Catalent) (US) Main Product
Table 67. Cook Pharmica LLC (Catalent) (US) Recent Development
Table 68. Patheon Inc. (Netherlands) Large Volume Parenterals (LVP) Corporation Information
Table 69. Patheon Inc. (Netherlands) Corporation Information
Table 70. Patheon Inc. (Netherlands) Large Volume Parenterals (LVP) Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2015-2020)
Table 71. Patheon Inc. (Netherlands) Main Product
Table 72. Patheon Inc. (Netherlands) Recent Development
Table 73. BAG Healthcare (Germany) Large Volume Parenterals (LVP) Corporation Information
Table 74. BAG Healthcare (Germany) Corporation Information
Table 75. BAG Healthcare (Germany) Large Volume Parenterals (LVP) Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2015-2020)
Table 76. BAG Healthcare (Germany) Main Product
Table 77. BAG Healthcare (Germany) Recent Development
Table 78. Southwest Pharmaceutical Co. Ltd. (China) Large Volume Parenterals (LVP) Corporation Information
Table 79. Southwest Pharmaceutical Co. Ltd. (China) Corporation Information
Table 80. Southwest Pharmaceutical Co. Ltd. (China) Large Volume Parenterals (LVP) Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2015-2020)
Table 81. Southwest Pharmaceutical Co. Ltd. (China) Main Product
Table 82. Southwest Pharmaceutical Co. Ltd. (China) Recent Development
Table 83. Beximco Pharma (Bangladesh) Large Volume Parenterals (LVP) Corporation Information
Table 84. Beximco Pharma (Bangladesh) Corporation Information
Table 85. Beximco Pharma (Bangladesh) Large Volume Parenterals (LVP) Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2015-2020)
Table 86. Beximco Pharma (Bangladesh) Main Product
Table 87. Beximco Pharma (Bangladesh) Recent Development
Table 88. Baxter Healthcare Corporation (US) Large Volume Parenterals (LVP) Corporation Information
Table 89. Baxter Healthcare Corporation (US) Corporation Information
Table 90. Baxter Healthcare Corporation (US) Large Volume Parenterals (LVP) Sales (K L), Revenue (Million US$), Price (USD/L) and Gross Margin (2015-2020)
Table 91. Baxter Healthcare Corporation (US) Main Product
Table 92. Baxter Healthcare Corporation (US) Recent Development
Table 93. Sales Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Large Volume Parenterals (LVP) Distributors List
Table 96. Large Volume Parenterals (LVP) Customers List
Table 97. Market Key Trends
Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 99. Key Challenges
Table 100. Global Large Volume Parenterals (LVP) Sales (K L) Forecast by Type (2021-2026)
Table 101. Global Large Volume Parenterals (LVP) Sales Market Share Forecast by Type (2021-2026)
Table 102. Global Large Volume Parenterals (LVP) Revenue (Million US$) Forecast by Type (2021-2026)
Table 103. Global Large Volume Parenterals (LVP) Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 104. Global Large Volume Parenterals (LVP) Sales (K L) Forecast by Application (2021-2026)
Table 105. Global Large Volume Parenterals (LVP) Revenue (Million US$) Forecast by Application (2021-2026)
Table 106. Global Large Volume Parenterals (LVP) Sales (K L) Forecast by Region (2021-2026)
Table 107. Global Large Volume Parenterals (LVP) Sales Market Share Forecast by Region (2021-2026)
Table 108. Global Large Volume Parenterals (LVP) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Global Large Volume Parenterals (LVP) Revenue Market Share Forecast by Region (2021-2026)
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Large Volume Parenterals (LVP)
Figure 2. Global Large Volume Parenterals (LVP) Sales Market Share by Type: 2020 VS 2026
Figure 3. Fluid Balance Injections Product Picture
Figure 4. Therapeutic Injections Product Picture
Figure 5. Nutritious Injections Product Picture
Figure 6. Global Large Volume Parenterals (LVP) Consumption Market Share by Application: 2020 VS 2026
Figure 7. Intravenous
Figure 8. Intramuscular
Figure 9. Subcutaneous
Figure 10. Others
Figure 11. Global Large Volume Parenterals (LVP) Market Size 2015-2026 (US$ Million)
Figure 12. Global Large Volume Parenterals (LVP) Sales Capacity (K L) (2015-2026)
Figure 13. Global Large Volume Parenterals (LVP) Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Large Volume Parenterals (LVP) Sales Share by Manufacturers in 2020
Figure 15. Global Large Volume Parenterals (LVP) Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Large Volume Parenterals (LVP) Revenue in 2019
Figure 17. Large Volume Parenterals (LVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Large Volume Parenterals (LVP) Sales Market Share by Region (2015-2020)
Figure 19. Global Large Volume Parenterals (LVP) Sales Market Share by Region in 2019
Figure 20. Global Large Volume Parenterals (LVP) Revenue Market Share by Region (2015-2020)
Figure 21. Global Large Volume Parenterals (LVP) Revenue Market Share by Region in 2019
Figure 22. North America Large Volume Parenterals (LVP) Sales Market Share by Country in 2019
Figure 23. North America Large Volume Parenterals (LVP) Revenue Market Share by Country in 2019
Figure 24. U.S. Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 25. U.S. Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 27. Canada Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Large Volume Parenterals (LVP) Sales Market Share by Country in 2019
Figure 29. Europe Large Volume Parenterals (LVP) Revenue Market Share by Country in 2019
Figure 30. Germany Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 31. Germany Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 33. France Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 35. U.K. Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 37. Italy Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 39. Russia Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Large Volume Parenterals (LVP) Sales Market Share by Region in 2019
Figure 41. Asia Pacific Large Volume Parenterals (LVP) Revenue Market Share by Region in 2019
Figure 42. China Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 43. China Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 45. Japan Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 47. South Korea Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 49. India Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 51. Australia Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 53. Taiwan Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 55. Indonesia Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 57. Thailand Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 59. Malaysia Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 61. Philippines Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 63. Vietnam Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Large Volume Parenterals (LVP) Sales Market Share by Country in 2019
Figure 65. Latin America Large Volume Parenterals (LVP) Revenue Market Share by Country in 2019
Figure 66. Mexico Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 67. Mexico Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 69. Brazil Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 71. Argentina Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Large Volume Parenterals (LVP) Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Large Volume Parenterals (LVP) Revenue Market Share by Country in 2019
Figure 74. Turkey Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 75. Turkey Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 77. Saudi Arabia Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. U.A.E Large Volume Parenterals (LVP) Sales Growth Rate (2015-2020) (K L)
Figure 79. U.A.E Large Volume Parenterals (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Large Volume Parenterals (LVP) by Type (2015-2020)
Figure 81. Sales Market Share of Large Volume Parenterals (LVP) by Type in 2019
Figure 82. Revenue Share of Large Volume Parenterals (LVP) by Type (2015-2020)
Figure 83. Revenue Market Share of Large Volume Parenterals (LVP) by Type in 2019
Figure 84. Global Large Volume Parenterals (LVP) Sales Growth by Type (2015-2020) (K L)
Figure 85. Global Large Volume Parenterals (LVP) Sales Market Share by Application (2015-2020)
Figure 86. Global Large Volume Parenterals (LVP) Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Large Volume Parenterals (LVP) by Application (2015-2020)
Figure 88. Global Revenue Share of Large Volume Parenterals (LVP) by Application in 2020
Figure 89. Ostuka Pharmaceutical (Japan) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Teva Pharmaceutical Industries Limited (Israel) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Kelun Pharma (China) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Cook Pharmica LLC (Catalent) (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Patheon Inc. (Netherlands) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. BAG Healthcare (Germany) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Southwest Pharmaceutical Co. Ltd. (China) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Beximco Pharma (Bangladesh) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Baxter Healthcare Corporation (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Price Trend of Key Raw Materials
Figure 99. Manufacturing Cost Structure of Large Volume Parenterals (LVP)
Figure 100. Manufacturing Process Analysis of Large Volume Parenterals (LVP)
Figure 101. Large Volume Parenterals (LVP) Industrial Chain Analysis
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. North America Large Volume Parenterals (LVP) Sales (K L) and Growth Rate Forecast (2021-2026)
Figure 106. North America Large Volume Parenterals (LVP) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Large Volume Parenterals (LVP) Sales (K L) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Large Volume Parenterals (LVP) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Large Volume Parenterals (LVP) Sales (K L) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Large Volume Parenterals (LVP) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Large Volume Parenterals (LVP) Sales (K L) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Large Volume Parenterals (LVP) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Large Volume Parenterals (LVP) Sales (K L) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Large Volume Parenterals (LVP) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs